An assessment model for efficacy of autologous CD19 chimeric antigen receptor T-cell therapy and relapse or refractory diffuse large B-cell lymphoma risk

被引：0
|
作者：
Xue, Bin [1 ]
Liu, Yifan [1 ]
Zhang, Min [1 ]
Xiao, Gangfeng [1 ,2 ]
Luo, Xiu [1 ]
Zhou, Lili [1 ]
Ye, Shiguang [1 ]
Lu, Yan [1 ]
Qian, Wenbin [3 ]
Wang, Li [4 ]
Li, Ping [1 ]
Liang, Aibin [1 ]
机构：
[1] Tongji Univ, Sch Med, Shanghai Tongji Hosp, Dept Hematol, Shanghai 200065, Peoples R China
[2] Ningbo No 2 Hosp, Dept Hematol, Ningbo 315010, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 2, Coll Med, Dept Hematol, Hangzhou 310009, Zhejiang, Peoples R China
[4] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Hematol, Shanghai 200001, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2025年 / 138卷 / 01期
基金：
国家重点研发计划; 上海市自然科学基金; 中国国家自然科学基金;
关键词：
D O I：
10.1097/CM9.0000000000003343
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：108 / 110
页数：3
相关论文
共 50 条
  • [41] Evaluation of the safety and efficacy of humanized anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma based on the comprehensive geriatric assessment system
    Zhang, Huan
    Liu, Man
    Li, Qing
    Lyu, Cuicui
    Jiang, Yan-Yu
    Meng, Juan-Xia
    Li, Jing-Yi
    Deng, Qi
    LEUKEMIA & LYMPHOMA, 2022, 63 (02) : 353 - 361
  • [42] A New Frontier: CD19 Chimeric Antigen Receptor T-Cell Therapy
    Alkureishi, Lolita Alcocer
    Hageman, Joseph R.
    PEDIATRIC ANNALS, 2024, 53 (05): : e157 - e158
  • [43] Radiation Prior to Chimeric Antigen Receptor T-Cell Therapy Is an Optimizing Bridging Strategy in Relapse/Refractory Aggressive B-Cell Lymphoma
    Yu, Qiuxia
    Zhang, Xiaoying
    Wang, Na
    Huang, Liang
    Li, Chunrui
    Zhang, Yicheng
    Zhou, Jianfeng
    Wang, Gaoxiang
    Cao, Yang
    BLOOD, 2022, 140 : 10311 - 10312
  • [44] CD19/CD22 chimeric antigen receptor (CAR) T-cell cocktail therapy following autologous transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma on 18F-FDG PET/CT: a case description
    Zhou, Yeye
    Sang, Shibiao
    Zhang, Bin
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2023, 13 (07) : 4756 - 4761
  • [45] Bullous and Exanthematous Lesions Associated With Chimeric Antigen Receptor T-Cell Therapy in a Patient With Diffuse Large B-Cell Lymphoma
    Hu, Yongxian
    Zheng, Weiyan
    Qiao, Jianjun
    Cui, Qu
    Zhu, Yuanyuan
    Chang, Alex H.
    Huang, He
    JAMA DERMATOLOGY, 2020, 156 (09) : 1026 - 1028
  • [46] Chylothorax after chimeric antigen receptor T cell therapy for relapsed and refractory diffuse large B-cell lymphoma: A case report
    Chen, Hsin-Hui
    Kuo, Cheng-Yi
    Ho, Ching-Liang
    Chen, Yeu-Chin
    MEDICINE, 2023, 102 (41) : E35432
  • [47] Prophylactic Tocilizumab in Patients with Relapsed Refractory Lymphoma Treated with Anti CD19 Chimeric Antigen Receptor T-Cell Therapy
    Ahmed, Nausheen
    Caimi, Paolo
    Reese, Jane S.
    Otegbeye, Folashade
    Patel, Seema
    Schneider, Dina
    Boughan, Kirsten M.
    Cooper, Brenda
    Gallogly, Molly
    Kruger, Winfred
    Worden, Andrew
    Kadan, Michael
    Lopes, Filipa Blasco Tavares Pereira
    Sharma, Ashish
    Malek, Ehsan
    Metheny, Leland
    Tomlinson, Benjamin
    Wald, David
    Sekaly, Rafick-Pierre
    Orentas, Rimas
    Dropulic, Boro
    de Lima, Marcos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S275 - S276
  • [48] Chimeric antigen receptor T-cell therapy after allogeneic stem cell transplant for relapsed/refractory large B-cell lymphoma
    Lutfi, Forat
    Holtzman, Noa
    Siglin, Jonathan
    Bukhari, Ali
    Mustafa Ali, Moaath
    Kim, Dong
    Sanchez-Petitto, Gabriela
    Gottlieb, David
    Ruehle, Kathleen
    Hutnick, Elizabeth
    Gahres, Natalie
    Hankey, Kim
    Lee, Seung
    Kocoglu, Mehmet
    Yared, Jean
    Hardy, Nancy
    Rapoport, Aaron
    Dahiya, Saurabh
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (01) : 212 - 216
  • [49] Outcomes of CD19 Chimeric Antigen Receptor T Cell Therapy in Patients with Gastrointestinal Tract Involvement of Large B Cell Lymphoma
    Cortes-Bullich, Albert
    Perez, Ariel
    Bachmeier, Christina
    Mhaskar, Rahul
    Chavez, Julio C.
    Shah, Bijal
    Nishihori, Taiga
    Khimani, Farhad
    Lazaryan, Aleksandr
    Davila, Marco L.
    Locke, Frederick L.
    Jain, Michael D.
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (09): : 768.e1 - 768.e6
  • [50] Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma
    Lin, John K.
    Muffly, Lori S.
    Spinner, Michael A.
    Barnes, James, I
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (24) : 2105 - +
12345